SlideShare a Scribd company logo
1 of 72
Evidence-Based Clinical Practice Guidelines
4/5/2022
1
Evidence-based medicine (EBM)
 EBM is a philosophy of practice and an approach to decision-
making in the clinical care of patients.
 The conscientious, explicit, and judicious use of current best
evidence in making decisions about the care of individual patients.
 Evidence-based clinical practice requires integration of
Individual clinical expertise and patient preferences with,
The best available external clinical evidence from systematic
research and consideration of available resources.
 EBM requires both clinical expertise and an intimate knowledge
of the individual patient’s situation, beliefs, priorities, and values to
be useful.
 External evidence must be used to inform, but not replace,
individual clinical expertise.
4/5/2022
2
4/5/2022
3
Steps of EBM
Step 1: Formulating a well-built question
Step 2: Identifying articles and other evidence- based resources that
answer the question
Step 3: Critically appraising the evidence to assess its validity
Step 4: Applying the evidence. Individualize, based clinical expertise
and patient concerns
Step 5: Re-evaluating the application of evidence and areas for
improvement .
4/5/2022
4
Evidence-based clinical practice guidelines
 Are systematically developed statements to assist practitioner and
patient decisions about health care for specific circumstances.
 Clinical practice guidelines are developed by a variety of groups
and organizations including
 Federal and state government,
 Professional societies and associations,
 Managed care organizations,
 Third-party payers,
 Quality assurance organizations, and
 Utilization review groups
4/5/2022
5
Evidence-based clinical practice guidelines…
 Updated practice guidelines provide a concise summary of current
best evidence on,
 what works and
 what does not when considering specific health care interventions
 Methods for development of valid practice guidelines emphasize
 evidence-based approach,
 formal quantitative techniques to calculate risks and benefits, and
 incorporation of the patient's preference
4/5/2022
6
Evidence-based clinical practice guidelines…
 Clinical Practice Guidelines vary in terms of :
 The purpose of the guidelines
Development methods used
Format of the documents, and
Strategies for implementation
Influence thousands to millions of decisions on medical
interventions
 The goals of development and implementation of evidence-based
clinical practice guidelines.
Is to help speed up the process of getting evidence into practice
To improve quality and efficiency of services
4/5/2022
7
Steps In Evidence-based CPG Development
 Major steps common in the evidence-based guideline development
process includes the following steps:
1. Select an appropriate topic for creation of a guideline
2. Recruit appropriate multidisciplinary membership for a panel to be
involved in development of the guideline
3. Define the clinical questions to be addressed
4. Determine the criteria for evidence that will be considered
5. Conduct a systematic search for the qualifying evidence
6. Perform a systematic evaluation and grading of the evidence
7. Prepare a synthesis of the evidence.
8. Agree on procedures for a consensus process, or other procedures for
making recommendations, in the absence of higher levels of evidence for
decision-making
9. Formulate and grade recommendations based on the grade of evidence and
balance of benefits, harms, and costs of treatment options
10. Draft the guideline document
11. Conduct peer-review and pilot testing of the guideline
12. Revise the guideline as appropriate
13. Create tools for implementation of the guideline
14. Establish a plan for follow-up and periodic updating of the guideline
4/5/2022
8
Select A Topic For Guideline Development
 High prevalence.
 High frequency and/or severity of associated morbidity or mortality.
 Availability of high-quality evidence for the efficacy of treatments
that reduce morbidity or mortality.
 Feasibility of implementation of the treatment based on expertise
and other resources required.
 Potential cost-effectiveness.
 Evidence that current practice is not optimal.
 Evidence of practice variation.
 Availability of personnel, expertise, and resources to develop and
implement the practice guideline.
4/5/2022
9
Ethical and Legal issues in Drug Information
 What is Ethics?
Ethics can be defined broadly as a set of moral principles or
values
Each of us has such a set of values
We may or may not have considered them explicitly
Veatch stated that “an ethical, or moral, issue involves judgments
between right and wrong human conduct or praiseworthy and
blameworthy human character”
4/5/2022
10
4/5/2022
11
 Ethical deliberation may be differentiated from other types of
decision-making by three characteristics:
1. It is ultimate or fundamental, there is no higher standard
against which to measure the rightness of the decision or
action
2. The issue is universal, the parties in disagreement do not
consider it simply a difference of opinion or taste- each party
believes there is a right or wrong answer- even if they’re not
sure what the answer is
3. The deliberation takes into account the welfare of all involved
or affected by the judgment at hand
Why People Act Unethically?
 The person’s ethical standards are different from those of
society as a whole
 The person chooses to act selfishly
In many instances, both reasons exist
Ethical Dilemmas in Pharmacy Practice
 An ethical dilemma (situation with unsatisfactory choices)
 is a situation a person faces in which a decision must be made about
appropriate behavior.
4/5/2022
12
Ethical Dilemmas in Pharmacy Practice….
4/5/2022
13
 All pharmacists who provide DI must address the ethical
dilemmas that arise in the course of providing this service
 Aspects of moral life that can prepare, guide and support
pharmacists faced with ethical during the course of providing
drug information:
Principles and rules
Moral emotions
Character and virtues, and
Rights
Resolving Ethical Dilemmas
1. Obtain the relevant facts
2. Identify the ethical issues from the facts
3. Determine who is affected
4. Identify the alternatives available to the person who must
resolve the dilemma
5. Identify the likely consequence of each alternative
6. Decide the appropriate action
4/5/2022
14
Ethics Analysis
 Beauchamp and Childress defined ethics as “a generic term for
several ways of examining the moral life”
 These authors described a process of deliberation and justification
that is necessary when confronting a moral dilemma
When we deliberate we are considering which judgment is
morally justified
They indicated that, “Particular judgments are justified by moral
rules, which in turn are justified by principles, which ultimately
are defended by an ethical theory”
4/5/2022
15
A hierarchical approach to analysis
4/5/2022
16
Contd…
 These hierarchical levels of analysis (particularly rules and
principles) used as action-guides, which are utilized to justify a
particular judgment
 Rule of ethics is specific to context and relatively restricted in scope;
for instance, the moral rule about confidentiality that specifically
addresses a patient’s right to consent prior to release of privileged
information
 Principles are more broad and fundamental in scope; for example, the
principle of respect for autonomy, which is the patient’s right to decide
on personal issues
 Ethical theories is integrated bodies of principles and rules that
may include mediating rules that govern cases of conflicts.
4/5/2022
17
Ethical theories
 The prominent rules and principles guiding ethical decision-
making by health care professionals can generally be placed within
one of two broad ethical theories:
Consequentialist theory or
 deontological (derived from the greek word deon, meaning
duty) theory
4/5/2022
18
Consequentialist theories
 Describe actions or decisions as morally right or wrong based on
their consequences, rather than on any intrinsic features they may
have
 Two cardinal principles
Beneficence (do that which at promotes a good outcome)
Nonmaleficence (do that which minimizes bad outcomes)
 For example, an informed consent ethical rule can be of value
within consequentialist theory because consent generally results in
improved compliance and outcome good consequences
4/5/2022
19
Duty driven (deontological) theories
 Look more to intrinsic qualities of an act or decision to assert its
moral rightness or wrongness
 Consider other inherent features of an act, besides consequences, as
also relevant and often of greater importance
 For example, in various forms of deontological theory, the act is
considered inherently wrong.
if it is dishonest or
breaks confidentiality, or
if it does not respect individual autonomy
4/5/2022
20
Analyzing Ethical Dilemmas
 Veatch indicated that often we reach particular ethical decision
Without a great deal of conscious deliberation
Through our moral intuition, and
Without subsequent challenge from any external party
 However, on occasion, when pondering consider carefully a certain
ethical judgment, we are called on (internally or externally) to
analyze and justify the basis for our conviction
 when this occurs,
 it is first important to understand the facts of the specific case
 then described progression through three additional process stages of
reflection (on ethical rules, principles, and theories) by which we may
identify, analyze, and present reasons for our judgment
4/5/2022
21
Process of Ethical Analysis
I. Identification of relevant background information
A. Factual details of the issue at hand
B. Consideration of who is affected by the ethical issue
C. Learn and respectfully address the cultural perspectives
(including applicable legal requirements) for those affected by
the dilemma
II. Identification and justification of the relevant moral rules and
principles (action-guides) pertinent to the case
III. Deliberation, long careful consideration of something, through
the use of moral intuition and application of ethical theory, on
how to rank/balance the rules and principles pertinent to the case
in order to resolve the ethical dilemma
4/5/2022
22
Step I. Identification of Relevant Background Information
 This first step deserves careful consideration and research
 Once the facts of a case are known, the moral concerns
may be resolved.
 This step has been divided into three parts:
Data gathering
Consideration of the welfare of all affected parties
Respect for the cultural perspectives of these parties
4/5/2022
23
Step II: Use of Rules and Principles (Action-Guides) to Assist in
Analysis of an Ethical Dilemma
 This second process step of analysis will look at moral rules that
may apply to the specific case, as well as at more general pertinent
ethical principles
 Defining the relevant action-guides as rules or principles help in
assessing which are more fundamental to the issue at hand
4/5/2022
24
Step III: Ethical Theory as a Means to Clarify or Resolve
Ethical Dilemmas
 This third step of ethical analysis reveals how relevant moral rules
and principles interact within the preferred ethical theory to
address the given dilemma
 When confronted with conflicting ethical rules or principles, the
pharmacist may resolve the dilemma through his or her moral
intuition of “the right thing to do”
 this process step can lead to more rational and honest decision-
making or action-taking
4/5/2022
25
Ethical Rules and Principles (Action guides)
1. Nonmaleficence
 A basic principle of consequentialist theory; encompasses the
duty to do no harm.
 The obligation to avoid inflicting either physical or
psychological harm on others.
 This tenet has a long history as part of the Hippocratic tradition,
where it has often been described in terms of the health care
provider’s duty to the individual patient.
 The principle is also cited as justification for actions benefiting
all.
4/5/2022
26
2. Beneficence
 A basic principle of consequentialist theory that expresses the duty
to promote good.
 Again, conflict can arise between what constitutes “good” for one
individual versus the larger societal group.
 Good or bad consequences are also of importance within
deontological theories, but are evaluated along with other
principles that may be considered of equal or greater importance.
4/5/2022
27
3. Respecting the patient-professional relationship
 A moral rule, often referring to respect for the physicianpatient
relationship, but also applicable to other professional- patient
relationships, as well.
 As expressed in Hippocratic traditions, this rule indicates that the
physician’s primary duty is to the patient and tends to give the
physician, rather than the patient, control in the relationship.
 This rule is particularly noted in duty-driven (deontological)
ethical theories that consider the professional’s duty to the patient,
but also supports consequentialist theory to the extent that good
outcomes are enhanced.
4/5/2022
28
4. Respect for autonomy
 Principles described particularly within deontological theory.
 This principle is founded on a belief in the right of the individual to
self-rule.
 It speaks to the individual’s right to decide on issues that primarily
affect self.
5. Consent (give permission: agree)
 A moral rule related to the principle of autonomy which states that
the client has a right to be informed and to freely choose a course
of action;
For example, informed consent to receive a therapy or procedure
4/5/2022
29
6. Confidentiality
 A moral rule, also related to the principle of autonomy, which
specifically addresses the individual client’s right to give or refuse
consent relative to release of privileged information
7. Privacy
 Another rule within the principle of autonomy, more generally
relating to the right of the individual to control his or her own
affairs without interference from or knowledge of outside parties
4/5/2022
30
8. Respect for persons
 A principle expressing duty to the welfare of the individual,
particularly described within religionbased deontological theories.
 This principle may also be expressed within dignity of life or
sanctity of human life principles.
 It has common elements with the respect for autonomy principle,
but addresses more directly a belief in the inherent value of human
life, independent of characteristics or abilities of the specific
human being
4/5/2022
31
9. Veracity
 This term addresses the obligation to truth telling or honesty.
Veracity is considered an ethical principle within deontological
theory.
 However, it is considered a useful rule within consequentialist
theory, to the extent that it promotes good
10. Fidelity
 Another principle of moral duty in deontological theory that
addresses the responsibility to be trustworthy and keep promises
11. Justice
 This concept has been presented within various principles that
relate to fairness and tendering what is due; providing that to which
the individual is entitled.
 A number of justice theories have also been developed to connect
and justify these various principles 4/5/2022
32
Legal Responsibility for the Provision of Drug Information
 Legal obligations of the DI specialist remain unclear
 Professional standards of performance may be used by courts as an
objective measuring tool for the standard of care
 Pharmacy profession is assuming an increased legal responsibility
to provide DI in the daily practice of pharmaceutical care
4/5/2022
33
Negligence
 Currently, most litigation concerning pharmacists involves
negligence (Direct or proximate cause of personal injury or death).
 Elements of negligence:
 Duty breached
 Damages
 Direct causation
 Defenses absent
When Evidence on:
 Information provided was materially deficient
 Deficient information was a proximate cause of injury suffered (or at
least a substantial contributing factor)
 Recipient reasonably relied on the information provided
 Information deficiency was due to failure to exercise reasonable care
 Pharmacist knew or should have known that the safety or health of another
may have depended on the accuracy of the information provided
4/5/2022
34
Duty Breached
 Duty must be a legal duty (not a moral or ethical duty)
 Current law provides little guidance for disclosure of DI for
questionable purposes
 Pharmacists must exercise independent professional judgment and
assume legal responsibility for that judgment, when exercised.
Reasonable care
 That which would be considered acceptable and responsible
 Recent cases against pharmacists have held that pharmacists who
gain information about the unique susceptibility of a patient are
liable for failure to warn of the risks
 The court held the pharmacist liable for failing to warn a patient on
theophylline of the interaction with erythromycin that produced
seizures and consequent brain damage
4/5/2022
35
DI provision leading to Liability
 Incomplete information
 Inappropriate quality information
 Outdated information
 Inappropriate analysis
 Dissemination of incorrect information
Inappropriate analysis
 Published studies for DICs have reported that 41 to 83% of
requested information is patient - specific or judgmental in nature
 In addition to liability for negligent information retrieval and
dissemination, the pharmacist's role involves information
interpretation, evaluation, and giving advice
4/5/2022
36
Defenses to Negligence and Malpractice
 Legal defenses can avoid or reduce liability
 Defenses include:
Statute of limitations
 Comparative or contributory negligence
Informed consent
Governmental immunity, etc
4/5/2022
37
Some liabilities
 Comparative negligence is the allocation of responsibility for
damages incurred between the plaintiff and defendant, based on the
relative negligence of the two
 Concurrent negligence is the wrongful acts or omissions of two or
more persons acting independently, but causing the same injury
 Vicarious liability is the imputation of liability on one person for
the actions of another
 Respondeat superior refers to the proposition that the employer is
responsible for the negligent acts of its agents or employees
4/5/2022
38
Quality Assurance as a Liability Reducing Factor
 Identify scope of activities and personnel requirements
 Develop and follow policies and procedures or formal call triaging
protocols
 Keep standard operating procedure manual available for
consultation.
 Avoid violations of statutes and regulations
 Do not recommend an unapproved use or dose; if a use differs
from the labeling, the requestor must be so notified
 Do not recommend a use or dose of a drug based solely on foreign
literature or animal studies
 Never extrapolate pediatric dosages from adult dosages
 Maintain knowledge of the current literature, new drug
applications and supplemental approvals, labeling changes, and
new warnings
4/5/2022
39
Quality Assurance as a Liability Reducing Factor…
 Do not present inadequate data or ignore contrary data
 Avoid overly enthusiastic or exaggerated efficacy and safety claims; do
not attempt to diagnose or treat acute poisoning — direct such inquiries
to a poison control center or an emergency room.
 Know the circumstances of the case and appropriate background
information (e.g., knowledge of causality criteria, laboratory findings,
concurrent drugs are necessary for adverse drug reaction inquiries;
special care is needed for drug identification questions, especially in
view of the surge of counterfeit drugs)
 Responses of new employees, students, residents should be checked —
document, document, document
 Maintain reasonable response time; if necessary prioritize requests
 Obtain peer concurrence or outside professional consultation, if
necessary
 Develop a QA mechanism to ensure that service is maintained at a high
level of quality (e.g., periodic audits or surveys)
4/5/2022
40
Labeling and Advertising
 Labeling: Written or oral information used to supplement or
explain a product, regardless of whether the information
accompanies the product
Requires full disclosure
 Advertisements
 Require a fair balance, meaning there must be a discussion of both
benefits and risks, so as not to be misleading, and substantial evidence
from clinical trials must be included for comparative claims
 Labeling and advertising liability
 Doctrine of over promotion, under which adequate warning is
alleged to have been diluted by communications failing to
adequately convey the full impact of the warning
 Promotion of off- label or non - FDA - approved indications
4/5/2022
41
Drug and Therapeutics Committee (DTC)
 DTC is a committee designated to ensure the safe and effective use
of medicines
 Role of the DTC
Evaluates the clinical use of drugs
Develops policies for managing drug use and administration
Manages the formulary system
4/5/2022
42
Functions of DTC
 Promote better quality of care & Rational use of drugs through:
Advising medical, pharmacy & admin. Staff
Developing drug policies and procedures
Evaluation and selection of formulary drugs
Promoting interventions to improve drug use
Identifying and assessing drug use problems
Managing ADRs and medication error
4/5/2022
43
Advisory Functions of a DTC
 Advise medical, administrative, and pharmacy departments
 Advise and support other hospital organizations on drug related
issues
 Participate in hospital committees and departments on all matters
concerning drugs
 DTC has the most expertise to develop policies on:
New, non-formulary, restricted, investigational drugs
Generic substitution and therapeutic interchange
Standard treatment guidelines (and other interventions)
Interventions to promote more rational use of drugs
4/5/2022
44
Evaluation and Selection of Drugs for the formulary
 Explicit evaluation criteria
efficacy, relative efficacy, effectiveness
safety, quality, cost
 Consistent decision-making
evidence-based, local context, transparency
 Use current literature
Primary literature (RCT)
Secondary (bulletins and reviews)
Reliable and current tertiary sources (textbooks)
4/5/2022
45
Identifying Drug Use Problems
 Prescribing
 Dispensing
 Drug Administration e.g. unsafe injections
 Adverse drug reactions
 Medication error
 Antimicrobial resistance surveillance
4/5/2022
46
Promoting Interventions to Improve Drug Use
 Educational programs
Drug bulletins and newsletters
 Managerial programs
Standard Treatment Guidelines
Drug utilisation evaluation or review (DUE / DUR)
Structured order forms, automatic stop orders
 Regulatory programs
Drug registration
Professional licensing
Licensing of outlets
 The DTC should: monitor, assess, report, correct the problem if
possible, prevent future problems of ADR and ME.
4/5/2022
47
4/5/2022
48
DTC: Structure and Organization
4/5/2022
49
Antimicrobial subcommittee
 to promote better use of antimicrobials
 Addresses issues relating to antimicrobial including prescribing
 Develops policies concerning use of antimicrobials for approval
by the DTC and medical staff
should specifically include sections on methods to limit and
restrict use of antimicrobials
 Assists in evaluating and selecting antimicrobials for the
formulary
 Organizes educational programs for health care staff
 Monitors antimicrobial resistance patterns
4/5/2022
50
DTCs: Guiding Principles
 Transparent and unbiased decision-making
Explicit criteria and process
Documentation
Absence of conflict of interest
 Objectivity
Evidence-based approach and levels of evidence
 Consistency
Are the drugs in the formulary and STGs consistent?
 Impact orientation
 indicators of process, impact and outcome
4/5/2022
51
Factors critical to success
 Factors critical to success include:
Clear goals and purpose
Wide representation - prescribers, nurses, pharmacists
no relation between DTC and manufacturers, suppliers
official status approved by the administration (local & MOH)
with strong management support
motivated, respected DTC members
respected and dynamic chairperson
Promotion & support by medical & pharmacy schools
4/5/2022
52
Impact and outcome indicators
 Drug selection
no. drugs in the hospital formulary
% prescribed drugs belonging to the hospital formulary
 Prescribing quality
% of patients treated in accordance with STGs
% of drug treatments meeting agreed criteria of DUE
 Drug Safety
Mortality and morbidity rates per annum due to adverse
consequences of drug use (ADRs and medication errors)
4/5/2022
53
Professional writing
 Writing is “to keep my job” or “to pass this course,”
 Why you write?
to inform, instruct, persuade, or entertain
 First three items are those usually considered in professional
writing.
 Fourth, whenever possible, will help convince people to read what
has been written.
4/5/2022
54
Steps to write: Preparing to Write
 Know the purpose
Expected endpoint
 Author (participated either)
Writing or Revising the article
Conception and design of the study
Analysis and interpretation of the data
Final approval of the version that is published
4/5/2022
55
Steps to write: Preparing to Write
 Not an author
Acquisition of funding
General supervision of the research group
 If not authors, acknowledge them
 Know the audience (Writing style)
Pure technical style: for professionals in the same field
Middle technical style: for everyone having some unifying
factor.
 Popular technical style: for general public (common language)
4/5/2022
56
Steps to write: Preparing to Write
 Know the requirements of the publisher
"Uniform Requirements for Manuscripts Submitted to
Biomedical Journals"
Scientific Style and Format.
The American Medical Association Manual of Style.
 General Rules of Writing
Do sufficient research before getting started
Requires a lot of practice
Organize the information
Goal : Prepare a clear, concise, complete, and correct document
4/5/2022
57
Checklist in Preparation of Written Materials
 Do research first
 Make the document look "professional"
 Use proper grammar and spelling
 Keep things simple and direct.
 Keep the document short
 Use active sentences.
 Cover things in whatever order is easiest
 Get everything down on paper before revising
4/5/2022
58
Checklist in Preparation of Written Materials…
 Avoid
Abbreviations and acronyms
The first person (e.g., I, we, and us).
Slash construction (e.g., he or she and him or her).
Contractions
 Cite other references wherever appropriate (and get permission to
do so where appropriate)
 Put yourself in the reader's position
 Edit, Edit, Edit!
4/5/2022
59
Document Sections
 Three main parts of a typical document
Introduction
Body
Conclusion
4/5/2022
60
Introduction
 Start out strong
 Inform the reader of what they can expect in the rest of the
document
 Clear objective for the existence of the document
 Background information (well referenced)
 Hypothesis (if a research)
 Not be a conclusion
4/5/2022
61
Body
 All of the details
 Concise (All necessary information)
 Logical order
 Keep an eye on the desired endpoint
 Avoid materials that identify patient (if not get consent)
 Put the information in your own words
 Plagiarism: Copying of another's words or ideas without properly
giving credit
 Copyright violations consist of copying another's work, even
with appropriate quotations and citation, without permission
 Avoid extensive quotations
4/5/2022
62
Conclusion
 Summarize it
 Correspond to the objective
 Follow the information presented in the body
 Avoid extrapolating beyond the information available
 Submission of the Document
 Completed, proofread, and edited document is ready to be
submitted to
Journal (cover letter to introduce the document)
Transfer of copyright forms
Conflict of interest disclosures (including financial)
Other items that will be found in the directions for authors for
that journal
4/5/2022
63
Drug evaluation monograph
 Drug formulary requires that drugs or drug classes be objectively
assessed based on scientific information.
e.g., efficacy, safety, uniqueness, cost, and other appropriate items.
 The way to decide which drug is best for formulary addition is to
rationally evaluate all aspects of the drug in relation to similar
agents.
 The issues that are evaluated include: dosage forms, packaging, requirements
of accrediting or quality assurance bodies, physician preferences, regulatory
issues, patient/nursing convenience, advertising, and consumer expectations.
 Drug evaluation monograph provides a structured method to
review the major features of a drug product.
 Once a monograph is prepared, it can easily be used as a
structured template or overview of a drug product.
 Allows for easy comparison or contrast to other products that may be used
for the same indication or that are in the same product class.
4/5/2022
64
Contents of Monograph
Introduction
 Institution name heading
 Generic Name: Can include other common, nonofficial names,
e.g., TPA for alteplase.
 Trade or Brand Name: If more than one, indicate company that
each is from.
 Manufacturer (or source of supply): Include website address.
 Therapeutic Category: For example, thrombolytic agent for
alteplase.
 Classification: Antigulants
 Status: Prescription, nonprescription, and/or controlled substance
schedule (if applicable).
 Similar Agents: A list of common treatments used for the same
indication(s).
4/5/2022
65
Contents of Monograph…
 Summary:
Includes a short summary of advantages and disadvantages of
the drug,
Particularly in relation to other drugs
 Treatments used for each major indication, and
 Any other significant information.
 Recommendations:
Indicate whether or not the drug should be added to the Drug
Formulary of an institution
Assuming they would have patients that would be treated for
illnesses where this drug.
Also indicate specific formulary status for the drug (i.e.,
uncontrolled, monitored, restricted, and conditional)
4/5/2022
66
Contents of Monograph…
 whether the drug will replace any other product that might
already be on the formulary.
 In addition, present any information on how the drug is to be
placed in any clinical guidelines.
 Body
 Pharmacologic Data
Mechanism of action (usually brief)
Bacterial spectrum (if applicable)
 Therapeutic Indications
FDA approved indications
clearly indicate they are not FDA approved.
How the drug, and similar drugs, fit into clinical guidelines.
Clinical comparison (abstract at least two studies
4/5/2022
67
Contents of Monograph…
 Bioavailability/Pharmacokinetics:
 A table summarizing the following, in comparison to the comparator
agent(s) can be very useful.
 Absorption, Distribution, Metabolism and Excretion
 Dosage Forms
 Forms and strengths: Compare to other agents
 Purity and composition information should be included for herbal and
alternative medications.
 Explain any special information needed for preparation and storage, in
comparison to other products.
 Dosage Range
 Adults, Children, Elderly and Renal or hepatic failure
 Special administration requirements
 Restrictions in distribution (e.g., physician needs to be certified to prescribe)
4/5/2022
68
Contents of Monograph…
 Known Adverse Effects/Toxicities
Frequency and type (a table comparing the drug to others can be
a clear and concise way of expressing this information)
Prevention of toxicity
Risk and benefit data
 Special Precautions:
Usually includes pregnancy and lactation
 Contraindications
 Drug Interactions:
Drug-drug
Drug-food
Drug-laboratory
4/5/2022
69
Contents of Monograph…
 Patient Safety Information
Includes medication error information
 Patient Monitoring Guidelines
Includes effectiveness, adverse effects, compliance, and other
appropriate items.
 Patient Information
 Name and description of the medication
 Dosage form
 Route of administration
 Duration of therapy
 Special directions and precautions
 Side effects
 Techniques for self-monitoring
 Proper storage
 Refill information
 What to do if a dose is missed
4/5/2022
70
Contents of Monograph…
 Cost Comparison:
 Use Average Wholesale Price (AWP) and institutional prices, and
 make sure there is a comparison with any similar products at
equivalent doses
 Date Presented to Pharmacy and Therapeutics Committee,
and Name and Title of the Person Preparing the Document
References
4/5/2022
71
4/5/2022
72

More Related Content

What's hot

Collaborative “Spaces” and Health Information Technology Design
Collaborative “Spaces” and Health Information Technology Design Collaborative “Spaces” and Health Information Technology Design
Collaborative “Spaces” and Health Information Technology Design Canadian Patient Safety Institute
 
Teleaudiology: Are patients and Clinicians Ready for it? 
Teleaudiology: Are patients and Clinicians Ready for it? Teleaudiology: Are patients and Clinicians Ready for it? 
Teleaudiology: Are patients and Clinicians Ready for it? Phonak
 
Ethics CPD workshop
Ethics CPD workshopEthics CPD workshop
Ethics CPD workshopMichael Rowe
 
Critically appraise evidence based findings
Critically appraise evidence based findingsCritically appraise evidence based findings
Critically appraise evidence based findingsBarryCRNA
 
Ebdm n concept of critical appraisal
Ebdm n concept of critical appraisalEbdm n concept of critical appraisal
Ebdm n concept of critical appraisalMonali2011
 
Basic Principles of Research Ethics
Basic Principles of Research EthicsBasic Principles of Research Ethics
Basic Principles of Research EthicsSCPS
 
An Operational Tool To Enhance One Health Interdisciplinary Massimo CANALI
An Operational Tool To Enhance One Health Interdisciplinary   Massimo CANALIAn Operational Tool To Enhance One Health Interdisciplinary   Massimo CANALI
An Operational Tool To Enhance One Health Interdisciplinary Massimo CANALIGlobal Risk Forum GRFDavos
 

What's hot (8)

Research ethics
Research ethicsResearch ethics
Research ethics
 
Collaborative “Spaces” and Health Information Technology Design
Collaborative “Spaces” and Health Information Technology Design Collaborative “Spaces” and Health Information Technology Design
Collaborative “Spaces” and Health Information Technology Design
 
Teleaudiology: Are patients and Clinicians Ready for it? 
Teleaudiology: Are patients and Clinicians Ready for it? Teleaudiology: Are patients and Clinicians Ready for it? 
Teleaudiology: Are patients and Clinicians Ready for it? 
 
Ethics CPD workshop
Ethics CPD workshopEthics CPD workshop
Ethics CPD workshop
 
Critically appraise evidence based findings
Critically appraise evidence based findingsCritically appraise evidence based findings
Critically appraise evidence based findings
 
Ebdm n concept of critical appraisal
Ebdm n concept of critical appraisalEbdm n concept of critical appraisal
Ebdm n concept of critical appraisal
 
Basic Principles of Research Ethics
Basic Principles of Research EthicsBasic Principles of Research Ethics
Basic Principles of Research Ethics
 
An Operational Tool To Enhance One Health Interdisciplinary Massimo CANALI
An Operational Tool To Enhance One Health Interdisciplinary   Massimo CANALIAn Operational Tool To Enhance One Health Interdisciplinary   Massimo CANALI
An Operational Tool To Enhance One Health Interdisciplinary Massimo CANALI
 

Similar to Drug informatics 2

Ch 3. framework for ethical analysis and ch 4 professional ethics
Ch 3. framework for ethical analysis and ch 4 professional ethicsCh 3. framework for ethical analysis and ch 4 professional ethics
Ch 3. framework for ethical analysis and ch 4 professional ethicsUniversity of Gondar
 
SAC330 Ethical decision making
SAC330 Ethical decision makingSAC330 Ethical decision making
SAC330 Ethical decision makingBealCollegeOnline
 
Ethical decision making & application sanction
Ethical decision making & application sanctionEthical decision making & application sanction
Ethical decision making & application sanctionEricKlein2019
 
Ethical decision making process
Ethical decision making processEthical decision making process
Ethical decision making processAnandu K P
 
Presentation 130318
Presentation 130318Presentation 130318
Presentation 130318TheQDog
 
Ppt policy report
Ppt policy reportPpt policy report
Ppt policy reportmariedave
 
Ethical decision making
Ethical decision makingEthical decision making
Ethical decision makingMaun Sadhu
 
MODULE 15 - HOW TO RESOLVE ETHICAL ISSUES IN CLINICAL PRACTICE
MODULE 15 - HOW TO RESOLVE ETHICAL ISSUES IN CLINICAL PRACTICEMODULE 15 - HOW TO RESOLVE ETHICAL ISSUES IN CLINICAL PRACTICE
MODULE 15 - HOW TO RESOLVE ETHICAL ISSUES IN CLINICAL PRACTICEDr Ghaiath Hussein
 
Ethical Decision Making Process
Ethical Decision Making ProcessEthical Decision Making Process
Ethical Decision Making ProcessCoky Fauzi Alfi
 
NURS90055 Ethics in Nursing
NURS90055 Ethics in NursingNURS90055 Ethics in Nursing
NURS90055 Ethics in NursingJoAnneMartin19
 
Healthcare Management EthicsNo one would deny clinical and
Healthcare Management EthicsNo one would deny clinical andHealthcare Management EthicsNo one would deny clinical and
Healthcare Management EthicsNo one would deny clinical andSusanaFurman449
 
STEPS OF THE ETHICAL STEPS OF THE ETHICAL DECISIONDECISION--.docx
STEPS OF THE ETHICAL STEPS OF THE ETHICAL DECISIONDECISION--.docxSTEPS OF THE ETHICAL STEPS OF THE ETHICAL DECISIONDECISION--.docx
STEPS OF THE ETHICAL STEPS OF THE ETHICAL DECISIONDECISION--.docxwhitneyleman54422
 
Topic for capstone .Implementing Opiod Risk assessment tool .docx
Topic for capstone .Implementing Opiod Risk assessment tool .docxTopic for capstone .Implementing Opiod Risk assessment tool .docx
Topic for capstone .Implementing Opiod Risk assessment tool .docxnanamonkton
 
Ethics & juresprudence by Dr. Abhishek gaur (8741095005)
Ethics & juresprudence by Dr. Abhishek gaur (8741095005)Ethics & juresprudence by Dr. Abhishek gaur (8741095005)
Ethics & juresprudence by Dr. Abhishek gaur (8741095005)Dr. Abhishek Ashok Sharma
 
Episode 4: Ethical Decision-making (Part 1)
Episode 4: Ethical Decision-making (Part 1)Episode 4: Ethical Decision-making (Part 1)
Episode 4: Ethical Decision-making (Part 1)John Gavazzi
 
ethical decision making and ethical committee.pptx
ethical decision making and ethical committee.pptxethical decision making and ethical committee.pptx
ethical decision making and ethical committee.pptxAnu Radha
 
Evidence-Based-Practice-The-Basic-Principles-vs-Dec-2015.pdf
Evidence-Based-Practice-The-Basic-Principles-vs-Dec-2015.pdfEvidence-Based-Practice-The-Basic-Principles-vs-Dec-2015.pdf
Evidence-Based-Practice-The-Basic-Principles-vs-Dec-2015.pdfJayaramB11
 

Similar to Drug informatics 2 (20)

Ch 3. framework for ethical analysis and ch 4 professional ethics
Ch 3. framework for ethical analysis and ch 4 professional ethicsCh 3. framework for ethical analysis and ch 4 professional ethics
Ch 3. framework for ethical analysis and ch 4 professional ethics
 
SAC330 Ethical decision making
SAC330 Ethical decision makingSAC330 Ethical decision making
SAC330 Ethical decision making
 
Ethical decision making & application sanction
Ethical decision making & application sanctionEthical decision making & application sanction
Ethical decision making & application sanction
 
Ethical decision making process
Ethical decision making processEthical decision making process
Ethical decision making process
 
Presentation 130318
Presentation 130318Presentation 130318
Presentation 130318
 
Ppt policy report
Ppt policy reportPpt policy report
Ppt policy report
 
Decision making
Decision makingDecision making
Decision making
 
Ethical decision making
Ethical decision makingEthical decision making
Ethical decision making
 
MODULE 15 - HOW TO RESOLVE ETHICAL ISSUES IN CLINICAL PRACTICE
MODULE 15 - HOW TO RESOLVE ETHICAL ISSUES IN CLINICAL PRACTICEMODULE 15 - HOW TO RESOLVE ETHICAL ISSUES IN CLINICAL PRACTICE
MODULE 15 - HOW TO RESOLVE ETHICAL ISSUES IN CLINICAL PRACTICE
 
Ethical Decision Making Process
Ethical Decision Making ProcessEthical Decision Making Process
Ethical Decision Making Process
 
Chapter 5
Chapter 5Chapter 5
Chapter 5
 
NURS90055 Ethics in Nursing
NURS90055 Ethics in NursingNURS90055 Ethics in Nursing
NURS90055 Ethics in Nursing
 
Healthcare Management EthicsNo one would deny clinical and
Healthcare Management EthicsNo one would deny clinical andHealthcare Management EthicsNo one would deny clinical and
Healthcare Management EthicsNo one would deny clinical and
 
STEPS OF THE ETHICAL STEPS OF THE ETHICAL DECISIONDECISION--.docx
STEPS OF THE ETHICAL STEPS OF THE ETHICAL DECISIONDECISION--.docxSTEPS OF THE ETHICAL STEPS OF THE ETHICAL DECISIONDECISION--.docx
STEPS OF THE ETHICAL STEPS OF THE ETHICAL DECISIONDECISION--.docx
 
ethics- desta.ppt
ethics- desta.pptethics- desta.ppt
ethics- desta.ppt
 
Topic for capstone .Implementing Opiod Risk assessment tool .docx
Topic for capstone .Implementing Opiod Risk assessment tool .docxTopic for capstone .Implementing Opiod Risk assessment tool .docx
Topic for capstone .Implementing Opiod Risk assessment tool .docx
 
Ethics & juresprudence by Dr. Abhishek gaur (8741095005)
Ethics & juresprudence by Dr. Abhishek gaur (8741095005)Ethics & juresprudence by Dr. Abhishek gaur (8741095005)
Ethics & juresprudence by Dr. Abhishek gaur (8741095005)
 
Episode 4: Ethical Decision-making (Part 1)
Episode 4: Ethical Decision-making (Part 1)Episode 4: Ethical Decision-making (Part 1)
Episode 4: Ethical Decision-making (Part 1)
 
ethical decision making and ethical committee.pptx
ethical decision making and ethical committee.pptxethical decision making and ethical committee.pptx
ethical decision making and ethical committee.pptx
 
Evidence-Based-Practice-The-Basic-Principles-vs-Dec-2015.pdf
Evidence-Based-Practice-The-Basic-Principles-vs-Dec-2015.pdfEvidence-Based-Practice-The-Basic-Principles-vs-Dec-2015.pdf
Evidence-Based-Practice-The-Basic-Principles-vs-Dec-2015.pdf
 

Recently uploaded

MICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxMICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxabhijeetpadhi001
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...jaredbarbolino94
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxEyham Joco
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxUnboundStockton
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.arsicmarija21
 

Recently uploaded (20)

MICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxMICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptx
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptx
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docx
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.
 

Drug informatics 2

  • 1. Evidence-Based Clinical Practice Guidelines 4/5/2022 1
  • 2. Evidence-based medicine (EBM)  EBM is a philosophy of practice and an approach to decision- making in the clinical care of patients.  The conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients.  Evidence-based clinical practice requires integration of Individual clinical expertise and patient preferences with, The best available external clinical evidence from systematic research and consideration of available resources.  EBM requires both clinical expertise and an intimate knowledge of the individual patient’s situation, beliefs, priorities, and values to be useful.  External evidence must be used to inform, but not replace, individual clinical expertise. 4/5/2022 2
  • 4. Steps of EBM Step 1: Formulating a well-built question Step 2: Identifying articles and other evidence- based resources that answer the question Step 3: Critically appraising the evidence to assess its validity Step 4: Applying the evidence. Individualize, based clinical expertise and patient concerns Step 5: Re-evaluating the application of evidence and areas for improvement . 4/5/2022 4
  • 5. Evidence-based clinical practice guidelines  Are systematically developed statements to assist practitioner and patient decisions about health care for specific circumstances.  Clinical practice guidelines are developed by a variety of groups and organizations including  Federal and state government,  Professional societies and associations,  Managed care organizations,  Third-party payers,  Quality assurance organizations, and  Utilization review groups 4/5/2022 5
  • 6. Evidence-based clinical practice guidelines…  Updated practice guidelines provide a concise summary of current best evidence on,  what works and  what does not when considering specific health care interventions  Methods for development of valid practice guidelines emphasize  evidence-based approach,  formal quantitative techniques to calculate risks and benefits, and  incorporation of the patient's preference 4/5/2022 6
  • 7. Evidence-based clinical practice guidelines…  Clinical Practice Guidelines vary in terms of :  The purpose of the guidelines Development methods used Format of the documents, and Strategies for implementation Influence thousands to millions of decisions on medical interventions  The goals of development and implementation of evidence-based clinical practice guidelines. Is to help speed up the process of getting evidence into practice To improve quality and efficiency of services 4/5/2022 7
  • 8. Steps In Evidence-based CPG Development  Major steps common in the evidence-based guideline development process includes the following steps: 1. Select an appropriate topic for creation of a guideline 2. Recruit appropriate multidisciplinary membership for a panel to be involved in development of the guideline 3. Define the clinical questions to be addressed 4. Determine the criteria for evidence that will be considered 5. Conduct a systematic search for the qualifying evidence 6. Perform a systematic evaluation and grading of the evidence 7. Prepare a synthesis of the evidence. 8. Agree on procedures for a consensus process, or other procedures for making recommendations, in the absence of higher levels of evidence for decision-making 9. Formulate and grade recommendations based on the grade of evidence and balance of benefits, harms, and costs of treatment options 10. Draft the guideline document 11. Conduct peer-review and pilot testing of the guideline 12. Revise the guideline as appropriate 13. Create tools for implementation of the guideline 14. Establish a plan for follow-up and periodic updating of the guideline 4/5/2022 8
  • 9. Select A Topic For Guideline Development  High prevalence.  High frequency and/or severity of associated morbidity or mortality.  Availability of high-quality evidence for the efficacy of treatments that reduce morbidity or mortality.  Feasibility of implementation of the treatment based on expertise and other resources required.  Potential cost-effectiveness.  Evidence that current practice is not optimal.  Evidence of practice variation.  Availability of personnel, expertise, and resources to develop and implement the practice guideline. 4/5/2022 9
  • 10. Ethical and Legal issues in Drug Information  What is Ethics? Ethics can be defined broadly as a set of moral principles or values Each of us has such a set of values We may or may not have considered them explicitly Veatch stated that “an ethical, or moral, issue involves judgments between right and wrong human conduct or praiseworthy and blameworthy human character” 4/5/2022 10
  • 11. 4/5/2022 11  Ethical deliberation may be differentiated from other types of decision-making by three characteristics: 1. It is ultimate or fundamental, there is no higher standard against which to measure the rightness of the decision or action 2. The issue is universal, the parties in disagreement do not consider it simply a difference of opinion or taste- each party believes there is a right or wrong answer- even if they’re not sure what the answer is 3. The deliberation takes into account the welfare of all involved or affected by the judgment at hand
  • 12. Why People Act Unethically?  The person’s ethical standards are different from those of society as a whole  The person chooses to act selfishly In many instances, both reasons exist Ethical Dilemmas in Pharmacy Practice  An ethical dilemma (situation with unsatisfactory choices)  is a situation a person faces in which a decision must be made about appropriate behavior. 4/5/2022 12
  • 13. Ethical Dilemmas in Pharmacy Practice…. 4/5/2022 13  All pharmacists who provide DI must address the ethical dilemmas that arise in the course of providing this service  Aspects of moral life that can prepare, guide and support pharmacists faced with ethical during the course of providing drug information: Principles and rules Moral emotions Character and virtues, and Rights
  • 14. Resolving Ethical Dilemmas 1. Obtain the relevant facts 2. Identify the ethical issues from the facts 3. Determine who is affected 4. Identify the alternatives available to the person who must resolve the dilemma 5. Identify the likely consequence of each alternative 6. Decide the appropriate action 4/5/2022 14
  • 15. Ethics Analysis  Beauchamp and Childress defined ethics as “a generic term for several ways of examining the moral life”  These authors described a process of deliberation and justification that is necessary when confronting a moral dilemma When we deliberate we are considering which judgment is morally justified They indicated that, “Particular judgments are justified by moral rules, which in turn are justified by principles, which ultimately are defended by an ethical theory” 4/5/2022 15
  • 16. A hierarchical approach to analysis 4/5/2022 16
  • 17. Contd…  These hierarchical levels of analysis (particularly rules and principles) used as action-guides, which are utilized to justify a particular judgment  Rule of ethics is specific to context and relatively restricted in scope; for instance, the moral rule about confidentiality that specifically addresses a patient’s right to consent prior to release of privileged information  Principles are more broad and fundamental in scope; for example, the principle of respect for autonomy, which is the patient’s right to decide on personal issues  Ethical theories is integrated bodies of principles and rules that may include mediating rules that govern cases of conflicts. 4/5/2022 17
  • 18. Ethical theories  The prominent rules and principles guiding ethical decision- making by health care professionals can generally be placed within one of two broad ethical theories: Consequentialist theory or  deontological (derived from the greek word deon, meaning duty) theory 4/5/2022 18
  • 19. Consequentialist theories  Describe actions or decisions as morally right or wrong based on their consequences, rather than on any intrinsic features they may have  Two cardinal principles Beneficence (do that which at promotes a good outcome) Nonmaleficence (do that which minimizes bad outcomes)  For example, an informed consent ethical rule can be of value within consequentialist theory because consent generally results in improved compliance and outcome good consequences 4/5/2022 19
  • 20. Duty driven (deontological) theories  Look more to intrinsic qualities of an act or decision to assert its moral rightness or wrongness  Consider other inherent features of an act, besides consequences, as also relevant and often of greater importance  For example, in various forms of deontological theory, the act is considered inherently wrong. if it is dishonest or breaks confidentiality, or if it does not respect individual autonomy 4/5/2022 20
  • 21. Analyzing Ethical Dilemmas  Veatch indicated that often we reach particular ethical decision Without a great deal of conscious deliberation Through our moral intuition, and Without subsequent challenge from any external party  However, on occasion, when pondering consider carefully a certain ethical judgment, we are called on (internally or externally) to analyze and justify the basis for our conviction  when this occurs,  it is first important to understand the facts of the specific case  then described progression through three additional process stages of reflection (on ethical rules, principles, and theories) by which we may identify, analyze, and present reasons for our judgment 4/5/2022 21
  • 22. Process of Ethical Analysis I. Identification of relevant background information A. Factual details of the issue at hand B. Consideration of who is affected by the ethical issue C. Learn and respectfully address the cultural perspectives (including applicable legal requirements) for those affected by the dilemma II. Identification and justification of the relevant moral rules and principles (action-guides) pertinent to the case III. Deliberation, long careful consideration of something, through the use of moral intuition and application of ethical theory, on how to rank/balance the rules and principles pertinent to the case in order to resolve the ethical dilemma 4/5/2022 22
  • 23. Step I. Identification of Relevant Background Information  This first step deserves careful consideration and research  Once the facts of a case are known, the moral concerns may be resolved.  This step has been divided into three parts: Data gathering Consideration of the welfare of all affected parties Respect for the cultural perspectives of these parties 4/5/2022 23
  • 24. Step II: Use of Rules and Principles (Action-Guides) to Assist in Analysis of an Ethical Dilemma  This second process step of analysis will look at moral rules that may apply to the specific case, as well as at more general pertinent ethical principles  Defining the relevant action-guides as rules or principles help in assessing which are more fundamental to the issue at hand 4/5/2022 24
  • 25. Step III: Ethical Theory as a Means to Clarify or Resolve Ethical Dilemmas  This third step of ethical analysis reveals how relevant moral rules and principles interact within the preferred ethical theory to address the given dilemma  When confronted with conflicting ethical rules or principles, the pharmacist may resolve the dilemma through his or her moral intuition of “the right thing to do”  this process step can lead to more rational and honest decision- making or action-taking 4/5/2022 25
  • 26. Ethical Rules and Principles (Action guides) 1. Nonmaleficence  A basic principle of consequentialist theory; encompasses the duty to do no harm.  The obligation to avoid inflicting either physical or psychological harm on others.  This tenet has a long history as part of the Hippocratic tradition, where it has often been described in terms of the health care provider’s duty to the individual patient.  The principle is also cited as justification for actions benefiting all. 4/5/2022 26
  • 27. 2. Beneficence  A basic principle of consequentialist theory that expresses the duty to promote good.  Again, conflict can arise between what constitutes “good” for one individual versus the larger societal group.  Good or bad consequences are also of importance within deontological theories, but are evaluated along with other principles that may be considered of equal or greater importance. 4/5/2022 27
  • 28. 3. Respecting the patient-professional relationship  A moral rule, often referring to respect for the physicianpatient relationship, but also applicable to other professional- patient relationships, as well.  As expressed in Hippocratic traditions, this rule indicates that the physician’s primary duty is to the patient and tends to give the physician, rather than the patient, control in the relationship.  This rule is particularly noted in duty-driven (deontological) ethical theories that consider the professional’s duty to the patient, but also supports consequentialist theory to the extent that good outcomes are enhanced. 4/5/2022 28
  • 29. 4. Respect for autonomy  Principles described particularly within deontological theory.  This principle is founded on a belief in the right of the individual to self-rule.  It speaks to the individual’s right to decide on issues that primarily affect self. 5. Consent (give permission: agree)  A moral rule related to the principle of autonomy which states that the client has a right to be informed and to freely choose a course of action; For example, informed consent to receive a therapy or procedure 4/5/2022 29
  • 30. 6. Confidentiality  A moral rule, also related to the principle of autonomy, which specifically addresses the individual client’s right to give or refuse consent relative to release of privileged information 7. Privacy  Another rule within the principle of autonomy, more generally relating to the right of the individual to control his or her own affairs without interference from or knowledge of outside parties 4/5/2022 30
  • 31. 8. Respect for persons  A principle expressing duty to the welfare of the individual, particularly described within religionbased deontological theories.  This principle may also be expressed within dignity of life or sanctity of human life principles.  It has common elements with the respect for autonomy principle, but addresses more directly a belief in the inherent value of human life, independent of characteristics or abilities of the specific human being 4/5/2022 31
  • 32. 9. Veracity  This term addresses the obligation to truth telling or honesty. Veracity is considered an ethical principle within deontological theory.  However, it is considered a useful rule within consequentialist theory, to the extent that it promotes good 10. Fidelity  Another principle of moral duty in deontological theory that addresses the responsibility to be trustworthy and keep promises 11. Justice  This concept has been presented within various principles that relate to fairness and tendering what is due; providing that to which the individual is entitled.  A number of justice theories have also been developed to connect and justify these various principles 4/5/2022 32
  • 33. Legal Responsibility for the Provision of Drug Information  Legal obligations of the DI specialist remain unclear  Professional standards of performance may be used by courts as an objective measuring tool for the standard of care  Pharmacy profession is assuming an increased legal responsibility to provide DI in the daily practice of pharmaceutical care 4/5/2022 33
  • 34. Negligence  Currently, most litigation concerning pharmacists involves negligence (Direct or proximate cause of personal injury or death).  Elements of negligence:  Duty breached  Damages  Direct causation  Defenses absent When Evidence on:  Information provided was materially deficient  Deficient information was a proximate cause of injury suffered (or at least a substantial contributing factor)  Recipient reasonably relied on the information provided  Information deficiency was due to failure to exercise reasonable care  Pharmacist knew or should have known that the safety or health of another may have depended on the accuracy of the information provided 4/5/2022 34
  • 35. Duty Breached  Duty must be a legal duty (not a moral or ethical duty)  Current law provides little guidance for disclosure of DI for questionable purposes  Pharmacists must exercise independent professional judgment and assume legal responsibility for that judgment, when exercised. Reasonable care  That which would be considered acceptable and responsible  Recent cases against pharmacists have held that pharmacists who gain information about the unique susceptibility of a patient are liable for failure to warn of the risks  The court held the pharmacist liable for failing to warn a patient on theophylline of the interaction with erythromycin that produced seizures and consequent brain damage 4/5/2022 35
  • 36. DI provision leading to Liability  Incomplete information  Inappropriate quality information  Outdated information  Inappropriate analysis  Dissemination of incorrect information Inappropriate analysis  Published studies for DICs have reported that 41 to 83% of requested information is patient - specific or judgmental in nature  In addition to liability for negligent information retrieval and dissemination, the pharmacist's role involves information interpretation, evaluation, and giving advice 4/5/2022 36
  • 37. Defenses to Negligence and Malpractice  Legal defenses can avoid or reduce liability  Defenses include: Statute of limitations  Comparative or contributory negligence Informed consent Governmental immunity, etc 4/5/2022 37
  • 38. Some liabilities  Comparative negligence is the allocation of responsibility for damages incurred between the plaintiff and defendant, based on the relative negligence of the two  Concurrent negligence is the wrongful acts or omissions of two or more persons acting independently, but causing the same injury  Vicarious liability is the imputation of liability on one person for the actions of another  Respondeat superior refers to the proposition that the employer is responsible for the negligent acts of its agents or employees 4/5/2022 38
  • 39. Quality Assurance as a Liability Reducing Factor  Identify scope of activities and personnel requirements  Develop and follow policies and procedures or formal call triaging protocols  Keep standard operating procedure manual available for consultation.  Avoid violations of statutes and regulations  Do not recommend an unapproved use or dose; if a use differs from the labeling, the requestor must be so notified  Do not recommend a use or dose of a drug based solely on foreign literature or animal studies  Never extrapolate pediatric dosages from adult dosages  Maintain knowledge of the current literature, new drug applications and supplemental approvals, labeling changes, and new warnings 4/5/2022 39
  • 40. Quality Assurance as a Liability Reducing Factor…  Do not present inadequate data or ignore contrary data  Avoid overly enthusiastic or exaggerated efficacy and safety claims; do not attempt to diagnose or treat acute poisoning — direct such inquiries to a poison control center or an emergency room.  Know the circumstances of the case and appropriate background information (e.g., knowledge of causality criteria, laboratory findings, concurrent drugs are necessary for adverse drug reaction inquiries; special care is needed for drug identification questions, especially in view of the surge of counterfeit drugs)  Responses of new employees, students, residents should be checked — document, document, document  Maintain reasonable response time; if necessary prioritize requests  Obtain peer concurrence or outside professional consultation, if necessary  Develop a QA mechanism to ensure that service is maintained at a high level of quality (e.g., periodic audits or surveys) 4/5/2022 40
  • 41. Labeling and Advertising  Labeling: Written or oral information used to supplement or explain a product, regardless of whether the information accompanies the product Requires full disclosure  Advertisements  Require a fair balance, meaning there must be a discussion of both benefits and risks, so as not to be misleading, and substantial evidence from clinical trials must be included for comparative claims  Labeling and advertising liability  Doctrine of over promotion, under which adequate warning is alleged to have been diluted by communications failing to adequately convey the full impact of the warning  Promotion of off- label or non - FDA - approved indications 4/5/2022 41
  • 42. Drug and Therapeutics Committee (DTC)  DTC is a committee designated to ensure the safe and effective use of medicines  Role of the DTC Evaluates the clinical use of drugs Develops policies for managing drug use and administration Manages the formulary system 4/5/2022 42
  • 43. Functions of DTC  Promote better quality of care & Rational use of drugs through: Advising medical, pharmacy & admin. Staff Developing drug policies and procedures Evaluation and selection of formulary drugs Promoting interventions to improve drug use Identifying and assessing drug use problems Managing ADRs and medication error 4/5/2022 43
  • 44. Advisory Functions of a DTC  Advise medical, administrative, and pharmacy departments  Advise and support other hospital organizations on drug related issues  Participate in hospital committees and departments on all matters concerning drugs  DTC has the most expertise to develop policies on: New, non-formulary, restricted, investigational drugs Generic substitution and therapeutic interchange Standard treatment guidelines (and other interventions) Interventions to promote more rational use of drugs 4/5/2022 44
  • 45. Evaluation and Selection of Drugs for the formulary  Explicit evaluation criteria efficacy, relative efficacy, effectiveness safety, quality, cost  Consistent decision-making evidence-based, local context, transparency  Use current literature Primary literature (RCT) Secondary (bulletins and reviews) Reliable and current tertiary sources (textbooks) 4/5/2022 45
  • 46. Identifying Drug Use Problems  Prescribing  Dispensing  Drug Administration e.g. unsafe injections  Adverse drug reactions  Medication error  Antimicrobial resistance surveillance 4/5/2022 46
  • 47. Promoting Interventions to Improve Drug Use  Educational programs Drug bulletins and newsletters  Managerial programs Standard Treatment Guidelines Drug utilisation evaluation or review (DUE / DUR) Structured order forms, automatic stop orders  Regulatory programs Drug registration Professional licensing Licensing of outlets  The DTC should: monitor, assess, report, correct the problem if possible, prevent future problems of ADR and ME. 4/5/2022 47
  • 49. DTC: Structure and Organization 4/5/2022 49
  • 50. Antimicrobial subcommittee  to promote better use of antimicrobials  Addresses issues relating to antimicrobial including prescribing  Develops policies concerning use of antimicrobials for approval by the DTC and medical staff should specifically include sections on methods to limit and restrict use of antimicrobials  Assists in evaluating and selecting antimicrobials for the formulary  Organizes educational programs for health care staff  Monitors antimicrobial resistance patterns 4/5/2022 50
  • 51. DTCs: Guiding Principles  Transparent and unbiased decision-making Explicit criteria and process Documentation Absence of conflict of interest  Objectivity Evidence-based approach and levels of evidence  Consistency Are the drugs in the formulary and STGs consistent?  Impact orientation  indicators of process, impact and outcome 4/5/2022 51
  • 52. Factors critical to success  Factors critical to success include: Clear goals and purpose Wide representation - prescribers, nurses, pharmacists no relation between DTC and manufacturers, suppliers official status approved by the administration (local & MOH) with strong management support motivated, respected DTC members respected and dynamic chairperson Promotion & support by medical & pharmacy schools 4/5/2022 52
  • 53. Impact and outcome indicators  Drug selection no. drugs in the hospital formulary % prescribed drugs belonging to the hospital formulary  Prescribing quality % of patients treated in accordance with STGs % of drug treatments meeting agreed criteria of DUE  Drug Safety Mortality and morbidity rates per annum due to adverse consequences of drug use (ADRs and medication errors) 4/5/2022 53
  • 54. Professional writing  Writing is “to keep my job” or “to pass this course,”  Why you write? to inform, instruct, persuade, or entertain  First three items are those usually considered in professional writing.  Fourth, whenever possible, will help convince people to read what has been written. 4/5/2022 54
  • 55. Steps to write: Preparing to Write  Know the purpose Expected endpoint  Author (participated either) Writing or Revising the article Conception and design of the study Analysis and interpretation of the data Final approval of the version that is published 4/5/2022 55
  • 56. Steps to write: Preparing to Write  Not an author Acquisition of funding General supervision of the research group  If not authors, acknowledge them  Know the audience (Writing style) Pure technical style: for professionals in the same field Middle technical style: for everyone having some unifying factor.  Popular technical style: for general public (common language) 4/5/2022 56
  • 57. Steps to write: Preparing to Write  Know the requirements of the publisher "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" Scientific Style and Format. The American Medical Association Manual of Style.  General Rules of Writing Do sufficient research before getting started Requires a lot of practice Organize the information Goal : Prepare a clear, concise, complete, and correct document 4/5/2022 57
  • 58. Checklist in Preparation of Written Materials  Do research first  Make the document look "professional"  Use proper grammar and spelling  Keep things simple and direct.  Keep the document short  Use active sentences.  Cover things in whatever order is easiest  Get everything down on paper before revising 4/5/2022 58
  • 59. Checklist in Preparation of Written Materials…  Avoid Abbreviations and acronyms The first person (e.g., I, we, and us). Slash construction (e.g., he or she and him or her). Contractions  Cite other references wherever appropriate (and get permission to do so where appropriate)  Put yourself in the reader's position  Edit, Edit, Edit! 4/5/2022 59
  • 60. Document Sections  Three main parts of a typical document Introduction Body Conclusion 4/5/2022 60
  • 61. Introduction  Start out strong  Inform the reader of what they can expect in the rest of the document  Clear objective for the existence of the document  Background information (well referenced)  Hypothesis (if a research)  Not be a conclusion 4/5/2022 61
  • 62. Body  All of the details  Concise (All necessary information)  Logical order  Keep an eye on the desired endpoint  Avoid materials that identify patient (if not get consent)  Put the information in your own words  Plagiarism: Copying of another's words or ideas without properly giving credit  Copyright violations consist of copying another's work, even with appropriate quotations and citation, without permission  Avoid extensive quotations 4/5/2022 62
  • 63. Conclusion  Summarize it  Correspond to the objective  Follow the information presented in the body  Avoid extrapolating beyond the information available  Submission of the Document  Completed, proofread, and edited document is ready to be submitted to Journal (cover letter to introduce the document) Transfer of copyright forms Conflict of interest disclosures (including financial) Other items that will be found in the directions for authors for that journal 4/5/2022 63
  • 64. Drug evaluation monograph  Drug formulary requires that drugs or drug classes be objectively assessed based on scientific information. e.g., efficacy, safety, uniqueness, cost, and other appropriate items.  The way to decide which drug is best for formulary addition is to rationally evaluate all aspects of the drug in relation to similar agents.  The issues that are evaluated include: dosage forms, packaging, requirements of accrediting or quality assurance bodies, physician preferences, regulatory issues, patient/nursing convenience, advertising, and consumer expectations.  Drug evaluation monograph provides a structured method to review the major features of a drug product.  Once a monograph is prepared, it can easily be used as a structured template or overview of a drug product.  Allows for easy comparison or contrast to other products that may be used for the same indication or that are in the same product class. 4/5/2022 64
  • 65. Contents of Monograph Introduction  Institution name heading  Generic Name: Can include other common, nonofficial names, e.g., TPA for alteplase.  Trade or Brand Name: If more than one, indicate company that each is from.  Manufacturer (or source of supply): Include website address.  Therapeutic Category: For example, thrombolytic agent for alteplase.  Classification: Antigulants  Status: Prescription, nonprescription, and/or controlled substance schedule (if applicable).  Similar Agents: A list of common treatments used for the same indication(s). 4/5/2022 65
  • 66. Contents of Monograph…  Summary: Includes a short summary of advantages and disadvantages of the drug, Particularly in relation to other drugs  Treatments used for each major indication, and  Any other significant information.  Recommendations: Indicate whether or not the drug should be added to the Drug Formulary of an institution Assuming they would have patients that would be treated for illnesses where this drug. Also indicate specific formulary status for the drug (i.e., uncontrolled, monitored, restricted, and conditional) 4/5/2022 66
  • 67. Contents of Monograph…  whether the drug will replace any other product that might already be on the formulary.  In addition, present any information on how the drug is to be placed in any clinical guidelines.  Body  Pharmacologic Data Mechanism of action (usually brief) Bacterial spectrum (if applicable)  Therapeutic Indications FDA approved indications clearly indicate they are not FDA approved. How the drug, and similar drugs, fit into clinical guidelines. Clinical comparison (abstract at least two studies 4/5/2022 67
  • 68. Contents of Monograph…  Bioavailability/Pharmacokinetics:  A table summarizing the following, in comparison to the comparator agent(s) can be very useful.  Absorption, Distribution, Metabolism and Excretion  Dosage Forms  Forms and strengths: Compare to other agents  Purity and composition information should be included for herbal and alternative medications.  Explain any special information needed for preparation and storage, in comparison to other products.  Dosage Range  Adults, Children, Elderly and Renal or hepatic failure  Special administration requirements  Restrictions in distribution (e.g., physician needs to be certified to prescribe) 4/5/2022 68
  • 69. Contents of Monograph…  Known Adverse Effects/Toxicities Frequency and type (a table comparing the drug to others can be a clear and concise way of expressing this information) Prevention of toxicity Risk and benefit data  Special Precautions: Usually includes pregnancy and lactation  Contraindications  Drug Interactions: Drug-drug Drug-food Drug-laboratory 4/5/2022 69
  • 70. Contents of Monograph…  Patient Safety Information Includes medication error information  Patient Monitoring Guidelines Includes effectiveness, adverse effects, compliance, and other appropriate items.  Patient Information  Name and description of the medication  Dosage form  Route of administration  Duration of therapy  Special directions and precautions  Side effects  Techniques for self-monitoring  Proper storage  Refill information  What to do if a dose is missed 4/5/2022 70
  • 71. Contents of Monograph…  Cost Comparison:  Use Average Wholesale Price (AWP) and institutional prices, and  make sure there is a comparison with any similar products at equivalent doses  Date Presented to Pharmacy and Therapeutics Committee, and Name and Title of the Person Preparing the Document References 4/5/2022 71